| Hyperglycemia in COVID-19 infection without diabetes mellitus: Association with inflammatory markers HS Geetha, G Singh, A Sekar, M Gogtay, Y Singh, GM Abraham, N Trivedi World Journal of Clinical Cases 11 (6), 1287, 2023 | 4 | 2023 |
| External Validation of PRISM Score in Multiple Myeloma Patients in a Community Setting: A Retrospective Cohort Study A Sekar, C Ramasamy, HS Geetha, MS Kumar, MP Syed, K Seetharaman, ... Blood 142, 4721, 2023 | 1 | 2023 |
| Implications of Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitor Use in the Incidence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) Amongst Patients With Type 2 … H Shanmugavel Geetha, MV Gogtay, NR Perkit, S Ravichandran, A Sekar, ... C55. COMORBIDITIES OF COPD: EPIDEMIOLOGY AND TREATMENT IMPLICATIONS, A5956-A5956, 2024 | | 2024 |
| Seven Days in the ICU; The Profound Storm of a Proliferative Disease H Shanmugavel Geetha, MG Suresh, A Sekar, A Gupta, GM Abraham C79. INFECTIONS AND CRITICAL ILLNESS: CHALLENGES IN THORACIC ONCOLOGY, A6573 …, 2024 | | 2024 |
| To Suction or to Not Suction; A Case of Persistent Air Leak Complicated by Respiratory Alkalosis H Shanmugavel Geetha, S Prabhu, A Sekar, D Markowitz C42. ALL ABOUT THE AIRWAYS AND ALVEOLI: RESPIRATORY FAILURE CASE REPORTS …, 2024 | | 2024 |
| Association of Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitor Use and Chronic Obstructive Pulmonary Disease (COPD) Outcomes Amongst Patients With Type 2 Diabetes Mellitus H Shanmugavel Geetha, MV Gogtay, NR Perkit, S Ravichandran, A Sekar, ... C55. COMORBIDITIES OF COPD: EPIDEMIOLOGY AND TREATMENT IMPLICATIONS, A5955-A5955, 2024 | | 2024 |
| 1520: AD-DRESS-ING AN UNUSUAL PRESENTATION OF VANCOMYCIN-INDUCED DRESS SYNDROME NR Perkit, A Sekar, HS Geetha, GM Abraham Critical Care Medicine 52 (1), S731, 2024 | | 2024 |
| Use of inflammatory markers as predictor for mechanical ventilation in COVID-19 patients with stages IIIb-V chronic kidney disease? HS Geetha, S Prabhu, A Sekar, M Gogtay, Y Singh, AK Mishra, ... World Journal of Virology 12 (5), 286, 2023 | | 2023 |
| AS THE LYMPHOMA EFFUSED A Singh, A Sekar, A Siddiqui CHEST 164 (4), A2485, 2023 | | 2023 |
| PROGNOSTIC VALUE OF NEUTROPHIL TO LYMPHOCYTE RATIO IN NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE COHORT STUDY A Sekar, S Shaik, NR Perkit, A Singh, C Ramasamy, Y Singh, ... CHEST 164 (4), A4206, 2023 | | 2023 |
| External validation of venous thromboembolism risk prediction models in patients with multiple myeloma in a community setting: A retrospective cohort study. C Ramasamy, A Sekar, H Shanmugavel Geetha, MS Kumar, MP Syed, ... Journal of Clinical Oncology 41 (16_suppl), e20027-e20027, 2023 | | 2023 |
| Impact of COVID-19 pandemic on lung cancer diagnosis in a community hospital. S Arun Kumar, A Sekar, A Singh, S Ravichandran, R Mishra, AD Siddiqui Journal of Clinical Oncology 41 (16_suppl), e18634-e18634, 2023 | | 2023 |
| Clinical Outcomes of New Onset Hyperglycemia in Non-diabetic Patients With COVID-19 Infection H Shanmugavel Geetha, M Gogtay, G Singh, A Sekar, GM Abraham C45. COVID AND ITS CONSEQUENCES: PART II, A5141-A5141, 2023 | | 2023 |
| Hidden in Plain Sight: A Case of Right Ventricular Thrombus A Sekar, H Shanmugavel Geetha, MG Suresh, C Salvan C62. CANCER, CLOTS, AND OTHER PULMONARY VASCULAR OBSTRUCTIONS, A5519-A5519, 2023 | | 2023 |
| NSIP/OP Overlap: An Unknown in Modern Era MG Suresh, A Sekar, P Arun Kumar, M Dasari, N Mohamed, M Beck B37. ILD CASE REPORTS: THE SPECTRUM FROM DIAGNOSIS TO TREATMENT, A3224-A3224, 2023 | | 2023 |
| Proton Pump Inhibitor (PPI) Use and COVID-19 Outcomes in Hospitalized Patients H Shanmugavel Geetha, S Prabhu, M Gogtay, G Singh, A Sekar, ... B106. FROM ACUTE TO LONG COVID-19, A4377-A4377, 2023 | | 2023 |
| 387: HYPERGLYCEMIA IN COVID-19 INFECTION WITHOUT DIABETES MELLITUS: ASSOCIATION WITH INFLAMMATORY MARKERS HS Geetha, M Gogtay, G Singh, A Sekar, G Abraham, N Trivedi Critical Care Medicine 51 (1), 180, 2023 | | 2023 |
| 1083: OUTCOMES OF COVID-19 INFECTION AMONG HOSPITALIZED PATIENTS BY THEIR STAGE OF CHRONIC KIDNEY DISEASE HS Geetha, M Gogtay, S Prabhu, A Sekar, Y Singh, G Abraham, S Martin Critical Care Medicine 51 (1), 536, 2023 | | 2023 |
| 245. Can Inflammatory Markers be used as an Early predictor for Mechanical ventilation in COVID-19 patients with Stages IIIb-V Chronic Kidney Disease? HS Geetha, M Gogtay, S Prabhu, A Sekar, Y Singh, GM Abraham, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 323, 2022 | | 2022 |
| Refining Clinical Risk Stratification for Estimating the Risk of Ischemic Stroke in Non-Atrial Fibrillation Patients with a Novel Risk Stratification Tool, CHA₂DS₂-Vasc+ Score A Sekar, M Gogtay, H Shanmugavel Geetha, A Sanghvi, Y Singh, ... Blood 140 (Supplement 1), 13031-13032, 2022 | | 2022 |
